#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	182	CRP	633	633	99.53	CRP.l15.c30.ctg.1	991	9.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	248	250	ACG	12;12;11	A;C;G	11;11;10	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	82	Chlamydophila_psittaci_16S	1507	97	94.85	Chlamydophila_psittaci_16S.l15.c4.ctg.4	97	7.2	0	.	n	.	0	G906T	SNP	906	906	G	6	6	T	1	T	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	82	Chlamydophila_psittaci_16S	1507	97	94.85	Chlamydophila_psittaci_16S.l15.c4.ctg.4	97	7.2	0	.	n	.	0	G908A	SNP	908	908	G	8	8	A	1	A	1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	82	Chlamydophila_psittaci_16S	1507	97	94.85	Chlamydophila_psittaci_16S.l15.c4.ctg.4	97	7.2	0	.	n	.	0	A918T	SNP	918	918	A	18	18	T	3	T	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	82	Chlamydophila_psittaci_16S	1507	97	94.85	Chlamydophila_psittaci_16S.l15.c4.ctg.4	97	7.2	0	.	n	.	0	A943G	SNP	943	943	A	43	43	G	12	G	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	82	Chlamydophila_psittaci_16S	1507	97	94.85	Chlamydophila_psittaci_16S.l15.c4.ctg.4	97	7.2	0	.	n	.	0	G991T	SNP	991	991	G	91	91	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	135	626	Escherichia_coli_EF_Tu	1185	1159	99.65	Escherichia_coli_EF_Tu.l15.c4.ctg.1	1219	23.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	135	626	Escherichia_coli_EF_Tu	1185	71	100.0	Escherichia_coli_EF_Tu.l15.c4.ctg.4	232	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	531	202	Escherichia_coli_mutant_1	1359	1331	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1340	7.4	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1332	1334	AAA	2;2;2	A;A;A	2;2;2	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	1	250	Escherichia_coli_mutant	1392	730	99.59	Escherichia_coli_mutant.l15.c4.ctg.1	730	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	1	250	Escherichia_coli_mutant	1392	254	99.21	Escherichia_coli_mutant.l15.c4.ctg.2	448	6.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	1	250	Escherichia_coli_mutant	1392	423	99.29	Escherichia_coli_mutant.l15.c4.ctg.3	461	6.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	79	81	GAA	7;7;7	G;A;A	7;7;6	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	16	48	H_NS	414	301	98.67	H_NS.l15.c30.ctg.1	301	5.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	224	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1288	8.9	0	.	p	.	0	H2R	NONSYN	4	6	CAT	64	66	CGT	8;10;10	C;G;T	8;10;10	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	224	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1288	8.9	0	.	p	.	0	D283G	NONSYN	847	849	GAC	907	909	GGC	8;8;7	G;G;C	8;8;7	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	286	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1759	8.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	51	53	AGC	4;4;4	A;G;C	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	286	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1759	8.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	453	455	CTA	5;5;5	C;T;A	5;5;5	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	286	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1759	8.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	972	974	CAA	14;13;15	C;A;A	14;13;15	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	286	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1759	8.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1071	1073	GGT	11;10;10	G;G;T	11;10;9	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	286	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1759	8.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1641	1643	GTT	3;3;2	G;T;T	3;3;2	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	80	PmrE	1167	395	99.75	PmrE.l6.c4.ctg.1	526	4.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	504	506	GAA	3;3;3	G;A;A	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	80	PmrE	1167	122	96.72	PmrE.l6.c4.ctg.2	126	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	80	PmrE	1167	112	98.21	PmrE.l6.c4.ctg.3	112	4.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	80	PmrE	1167	164	93.29	PmrE.l6.c4.ctg.4	164	2.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	8	10	ACT	1;1;1	A;C;T	1;1;1	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	80	PmrE	1167	150	98.0	PmrE.l6.c4.ctg.5	154	2.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	46	48	ATC	3;3;3	A;T;C	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	641	112	PmrF	969	394	99.24	PmrF.l15.c30.ctg.1	459	4.7	0	.	p	.	0	L220S	NONSYN	658	660	TTG	83	85	TCG	3;3;3	T;C,T;G	3;0,3;3	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	641	112	PmrF	969	394	99.24	PmrF.l15.c30.ctg.1	459	4.7	0	.	p	.	0	G296S	NONSYN	886	888	GGC	311	313	AGC	4;4;4	A,G;G;C	0,4;4;4	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	641	112	PmrF	969	555	98.92	PmrF.l15.c30.ctg.2	629	5.6	0	.	p	.	0	N66T	NONSYN	196	198	AAC	270	272	ACC	10;10;10	A;C,A;C	10;2,8;10	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_178.3001043.X97254.153_1011.1492	TEM_178.3001043.X97254.153_1011.1492	1	0	16	16	TEM_1+	858	89	100.0	TEM_1+.l15.c4.ctg.1	89	2.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-178 is an inhibitor-resistant, extended-spectrum beta-lactamase.;TEM-178
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	513	440	acrD	3114	1695	99.17	acrD.l6.c4.ctg.1	1838	6.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	547	549	AAG	3;3;4	A;A;G	3;3;4	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	513	440	acrD	3114	1415	99.01	acrD.l6.c4.ctg.2	1499	7.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	337	339	ATC	7;8;8	A;T;C	7;8;8	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	531	208	acrE	1158	1081	98.8	acrE.l15.c4.ctg.1	1183	8.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	728	730	TGC	17;17;16	T;G;C	17;16;16	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	P223R	NONSYN	667	669	CCA	3	5	CGA	4;4;4	C;G;A	1;1;1	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	54	56	TTA	2;1;2	T;T;A	2;1;2	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1131	1133	AAT	10;11;10	A;A;T	10;11;10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1245	1247	AGT	4;5;5	A;G;T	4;5;5	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	1644	1646	GTG	12;12;12	G;T;G	12;11;12	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	2441	98.77	acrF.l6.c4.ctg.1	2493	8.7	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2199	2201	AAG	5;5;4	A;A;G	5;5;4	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	676	98.67	acrF.l6.c4.ctg.2	693	8.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	153	153	T	3	T	3	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	513	534	acrF	3105	676	98.67	acrF.l6.c4.ctg.2	693	8.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	459	461	GAC	9;9;9	G;A;C	9;9;9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	132	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	862	7.3	1	SNP	p	R45C	0	.	.	133	135	CGC	269	271	CGC	8;8;8	C;G;C	8;8;8	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	108	acrS	663	663	98.79	acrS.l6.c4.ctg.1	802	6.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	178	180	TTC	9;9;9	T;T;C	9;9;9	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	108	acrS	663	663	98.79	acrS.l6.c4.ctg.1	802	6.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	442	444	GGG	7;7;7	G;G;G	7;7;7	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	124	adiY	762	762	99.61	adiY.l15.c4.ctg.1	972	6.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	556	558	CTT	10;9;10	C;T;T	10;9;10	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	518	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	2853	9.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2055	2057	GCA	14;14;14	G;C;A	13;14;14	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	518	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	2853	9.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2316	2318	ACC	12;12;12	A;C;C	12;12;12	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	518	alaS	2631	2631	98.82	alaS.l6.c4.ctg.1	2853	9.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2625	2627	GCC	8;8;7	G;C;C	8;8;7	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	798	99.12	arnA_1.l15.c4.ctg.1	798	8.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	7	9	GTT	1;2;2	G;T;T	1;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	798	99.12	arnA_1.l15.c4.ctg.1	798	8.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	157	159	CAC	9;9;9	C;A;C	9;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	798	99.12	arnA_1.l15.c4.ctg.1	798	8.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	442	444	ATG	12;12;12	A;T;G	12;12;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	157	96.82	arnA_1.l15.c4.ctg.2	157	3.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	22	24	TGC	3;3;3	T;G;C	3;3;3	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	189	98.41	arnA_1.l15.c4.ctg.3	272	7.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	85	87	CGC	6;6;6	C;G;C	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	111	99.1	arnA_1.l15.c4.ctg.4	124	2.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	172	99.42	arnA_1.l15.c4.ctg.5	172	3.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	142	99.3	arnA_1.l15.c4.ctg.6	142	4.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	240	arnA_1	1983	221	97.29	arnA_1.l15.c4.ctg.7	227	5.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	134	bacA	822	820	98.54	bacA.l6.c4.ctg.1	827	7.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	667	669	ACC	4;3;3	A;C;C	4;3;3	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	134	bacA	822	820	98.54	bacA.l6.c4.ctg.1	827	7.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	679	681	TCG	3;3;6	T;C;G	3;3;6	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	0	76	baeR	723	332	96.69	baeR.l6.c30.ctg.1	332	3.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	0	76	baeR	723	153	100.0	baeR.l6.c30.ctg.2	304	5.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	512	172	baeS	1404	129	96.12	baeS.l15.c4.ctg.2	129	4.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	4	6	GAG	1;2;2	G;A;G	1;2;2	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	512	172	baeS	1404	903	99.45	baeS.l15.c4.ctg.3	1001	6.8	0	.	p	.	0	A142T	NONSYN	424	426	GCG	522	524	ACG	12;12;12	A;C;G	12;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	512	172	baeS	1404	87	100.0	baeS.l15.c4.ctg.4	101	4.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	294	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1540	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	166	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1048	8.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	1	98	cysB	975	212	98.58	cysB.l15.c4.ctg.2	212	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	1	98	cysB	975	283	100.0	cysB.l15.c4.ctg.3	283	5.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	1	98	cysB	975	310	99.68	cysB.l15.c4.ctg.4	315	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	1	98	cysB	975	140	98.57	cysB.l15.c4.ctg.6	140	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	208	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1210	8.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	677	679	GTC	8;8;8	G;T;C	8;8;7	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	1	350	emrB	1539	539	100.0	emrB.l15.c4.ctg.1	711	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	1	350	emrB	1539	1001	99.7	emrB.l15.c4.ctg.2	1145	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	234	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1275	8.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	696	698	AGC	9;9;9	A;G;C	9;9;9	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	110	emrK	1056	1056	98.01	emrK.l6.c4.ctg.1	1112	4.6	0	.	p	.	0	S22F	NONSYN	64	66	TCT	107	109	TTT	1;1;1	T;T;T	1;1;1	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	110	emrK	1056	1056	98.01	emrK.l6.c4.ctg.1	1112	4.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	569	571	AGG	5;5;5	A;G;G	5;5;5	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	110	emrK	1056	1056	98.01	emrK.l6.c4.ctg.1	1112	4.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	959	961	GAC	4;4;3	G;A;C	4;4;3	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	82	emrR	531	531	100.0	emrR.l15.c30.ctg.1	670	5.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	220	emrY	1539	1539	99.81	emrY.l6.c4.ctg.1	1929	6.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	88	evgA	615	615	99.19	evgA.l15.c4.ctg.1	718	6.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	247	249	CTG	7;8;8	C;T;G	7;8;7	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	285	95.79	evgS.l6.c30.ctg.1	285	3.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	85	87	AAA	3;3;3	A;A;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	1312	99.16	evgS.l6.c30.ctg.2	1497	7.8	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	149	151	ATT	4;4;4	A;T;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	1312	99.16	evgS.l6.c30.ctg.2	1497	7.8	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	170	172	GAT	4;4;4	G;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	1312	99.16	evgS.l6.c30.ctg.2	1497	7.8	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	284	286	GTT	8;9;9	G;T;T	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	1312	99.16	evgS.l6.c30.ctg.2	1497	7.8	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	569	571	CAC	6;6;6	C;A;C	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	684	96.2	evgS.l6.c30.ctg.3	684	6.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	539	541	CAT	2;2;2	C;A;T	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	684	96.2	evgS.l6.c30.ctg.3	684	6.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	593	595	CAT	3;3;3	C;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	684	96.2	evgS.l6.c30.ctg.3	684	6.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	611	613	AGA	4;4;4	A;G;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	684	96.2	evgS.l6.c30.ctg.3	684	6.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	626	628	AAT	4;4;4	A;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	148	150	ATA	3;3;3	A;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	160	162	GTA	1;1;1	G;T;A	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	313	315	ACG	5;5;6	A;C;G	5;5;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	376	378	GAA	7;6;6	G;A;A	7;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	415	417	GCT	6;6;6	G;C;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	433	435	GAT	5;5;5	G;A;T	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	410	evgS	3594	487	97.33	evgS.l6.c30.ctg.4	570	6.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	520	522	TCA	7;7;7	T;C;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	146	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	915	7.8	1	SNP	p	P64S	0	.	.	190	192	CCA	221	223	CCA	10;11;12	C;C;A	10;11;10	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	146	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	915	7.8	1	SNP	p	P64A	0	.	.	190	192	CCA	221	223	CCA	10;11;12	C;C;A	10;11;10	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	146	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	915	7.8	1	SNP	p	P64H	0	.	.	190	192	CCA	221	223	CCA	10;11;12	C;C;A	10;11;10	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	146	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	915	7.8	1	SNP	p	P64L	0	.	.	190	192	CCA	221	223	CCA	10;11;12	C;C;A	10;11;10	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	146	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	915	7.8	1	SNP	p	P64R	0	.	.	190	192	CCA	221	223	CCA	10;11;12	C;C;A	10;11;10	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	106	gadE	528	528	100.0	gadE.l6.c4.ctg.1	750	6.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	24	gadW	729	119	97.48	gadW.l15.c4.ctg.1	119	3.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	132	gadX	825	777	97.94	gadX.l15.c4.ctg.2	778	7.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	158	160	TTA	8;8;8	T;T;A	8;8;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	132	gadX	825	777	97.94	gadX.l15.c4.ctg.2	778	7.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	236	238	ATT	6;5;4	A;T;T	6;5;4	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	132	gadX	825	777	97.94	gadX.l15.c4.ctg.2	778	7.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	737	739	GGA	6;6;6	G;G;A	6;6;6	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	132	gadX	825	777	97.94	gadX.l15.c4.ctg.2	778	7.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	743	745	CCG	5;5;5	C;C;G	5;5;5	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2100	2102	GAA	9;8;8	G;A;A	9;8;8	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	S83W	0	.	.	247	249	TCG	315	317	TCG	5;5;5	T;C;G	5;5;5	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	S83L	0	.	.	247	249	TCG	315	317	TCG	5;5;5	T;C;G	5;5;5	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	S83I	0	.	.	247	249	TCG	315	317	TCG	5;5;5	T;C;G	5;5;5	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	D87N	0	.	.	259	261	GAC	327	329	GAC	7;6;6	G;A;C	7;6;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	D87G	0	.	.	259	261	GAC	327	329	GAC	7;6;6	G;A;C	7;6;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	327	329	GAC	7;6;6	G;A;C	7;6;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	D87H	0	.	.	259	261	GAC	327	329	GAC	7;6;6	G;A;C	7;6;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	410	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	2855	7.6	1	SNP	p	D87V	0	.	.	259	261	GAC	327	329	GAC	7;6;6	G;A;C	7;6;6	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136I	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136G	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136L	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136C	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136S	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136E	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	492	gyrB_1	2415	2412	99.13	gyrB_1.l6.c4.ctg.1	2566	10.0	1	SNP	p	R136H	0	.	.	406	408	CGC	558	560	CGC	12;13;15	C;G;C	12;13;15	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	90	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	873	5.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	396	398	CCG	4;5;4	C;C;G	4;5;4	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	90	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	873	5.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	549	551	GCC	5;5;5	G;C;C	5;5;5	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	188	leuO	945	945	99.15	leuO.l15.c4.ctg.1	1145	8.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	73	75	TCA	8;7;9	T;C;A	8;7;9	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	531	188	leuO	945	945	99.15	leuO.l15.c4.ctg.1	1145	8.5	0	.	p	.	0	Q156trunc	TRUNC	466	466	C	514	514	T	7	T	7	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	48	marA	384	384	99.74	marA.l15.c30.ctg.1	567	4.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	0	20	marR	435	66	100.0	marR.l15.c4.ctg.1	66	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	0	20	marR	435	92	100.0	marR.l15.c4.ctg.2	92	2.3	1	SNP	p	V45E	0	.	.	133	135	GTG	44	46	GTG	4;4;4	G;T;G	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	0	20	marR	435	92	100.0	marR.l15.c4.ctg.2	92	2.3	1	SNP	p	I49S	0	.	.	145	147	ATC	56	58	ATC	3;3;3	A;T;C	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	12	14	GAT	3;3;3	G;A;T	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	33	35	ACC	3;3;3	A;C;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	60	62	TTA	5;5;4	T;T;A	5;5;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	V90G	NONSYN	268	270	GTG	126	128	GGG	4;4;4	G;G,T;G	4;0,3;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	W91G	NONSYN	271	273	TGG	129	131	GGG	4;4;4	G,T;G;G	0,3;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	201	203	CAG	8;7;7	C;A;G	8;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	D128A	NONSYN	382	384	GAC	240	242	GCC	3;3;3	G;C;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	531	97.18	mdfA.l6.c4.ctg.1	595	5.0	0	.	p	.	0	S163A	NONSYN	487	489	TCG	345	347	GCG	5;5;5	G;C;G	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	554	97.29	mdfA.l6.c4.ctg.2	549	6.0	0	.	p	.	0	L231V	NONSYN	691	693	CTT	19	21	GTT	2;2;2	G;T;T	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	554	97.29	mdfA.l6.c4.ctg.2	549	6.0	0	.	p	.	0	R285fs	FSHIFT	853	853	C	181	181	C	5	C	5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	103	96.12	mdfA.l6.c4.ctg.3	103	2.6	0	.	p	.	0	S7F	NONSYN	19	21	TCC	3	5	TTC	1;1;1	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	132	mdfA	1233	103	96.12	mdfA.l6.c4.ctg.3	103	2.6	0	.	p	.	0	R36I	NONSYN	106	108	AGG	90	92	ATC	4;4;4	A;T;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	199	95.48	mdtA.l15.c4.ctg.1	206	3.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	47	47	G	4	G	4	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	199	95.48	mdtA.l15.c4.ctg.1	206	3.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	104	106	CAG	3;4;4	C;A;G	3;4;4	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	483	98.55	mdtA.l15.c4.ctg.2	483	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	147	97.96	mdtA.l15.c4.ctg.4	149	2.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	17	19	ATG	2;2;2	A;T;G	2;2;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	147	97.96	mdtA.l15.c4.ctg.4	149	2.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	110	112	ACC	2;2;2	A;C;C	2;2;2	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	114	mdtA	1248	120	96.67	mdtA.l15.c4.ctg.5	120	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	65	67	GTT	3;3;3	G;T;T	3;3;3	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	173	175	GAG	6;6;7	G;A;G	6;6;7	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	V874G	NONSYN	2620	2622	GTG	293	295	GGG	8;8;7	G;G,T;G	8;3,4;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	V875G	NONSYN	2623	2625	GTG	296	298	GGG	5;5;6	G;G,T;G	5;0,4;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	401	403	ATG	9;9;10	A;T;G	9;9;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	694	97.41	mdtB.l15.c30.ctg.1	694	6.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	536	538	GAT	9;9;9	G;A;T	8;8;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	1748	99.54	mdtB.l15.c30.ctg.2	1748	7.2	0	.	p	.	0	T150P	NONSYN	448	450	ACG	20	22	CCG	4;4;4	C,A;C;G	0,3;3;3	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	1748	99.54	mdtB.l15.c30.ctg.2	1748	7.2	0	.	p	.	0	S545T	NONSYN	1633	1635	AGC	1205	1207	ACC	2;2;3	A;C,G;C	2;0,2;3	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	1748	99.54	mdtB.l15.c30.ctg.2	1748	7.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1319	1321	ACC	6;6;6	A;C;C	6;6;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	1748	99.54	mdtB.l15.c30.ctg.2	1748	7.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	1712	1714	CAA	8;8;8	C;A;A	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	512	440	mdtB	3123	448	99.55	mdtB.l15.c30.ctg.3	448	8.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	408	mdtC	3078	2882	98.85	mdtC.l6.c4.ctg.1	2945	7.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	199	201	ATG	5;4;4	A;T;G	5;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	408	mdtC	3078	2882	98.85	mdtC.l6.c4.ctg.1	2945	7.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	685	687	ATC	6;6;5	A;T;C	6;6;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	176	mdtD	1416	1061	98.21	mdtD.l6.c4.ctg.1	1082	6.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	321	323	GCG	4;4;4	G;C;G	4;4;4	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	176	mdtD	1416	1061	98.21	mdtD.l6.c4.ctg.1	1082	6.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	663	665	ATC	8;7;7	A;T;C	8;7;7	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	176	mdtD	1416	1061	98.21	mdtD.l6.c4.ctg.1	1082	6.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	966	968	TTT	10;10;10	T;T;T	10;10;10	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	176	mdtD	1416	139	99.28	mdtD.l6.c4.ctg.2	139	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	513	176	mdtD	1416	117	99.15	mdtD.l6.c4.ctg.3	117	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	322	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1292	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	634	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3306	10.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1021	1023	ACC	9;9;9	A;C;C	9;9;9	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	634	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3306	10.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2263	2265	GAC	11;11;11	G;A;C	11;11;11	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	528	154	mdtG	1227	668	99.1	mdtG.l6.c30.ctg.1	775	6.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	39	41	ATC	9;9;10	A;T;C	8;8;9	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	144	mdtH	1209	915	98.36	mdtH.l15.c4.ctg.2	918	7.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	400	402	TGT	14;14;14	T;G;T	14;14;14	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	144	mdtH	1209	101	96.04	mdtH.l15.c4.ctg.3	101	2.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	91	93	ACG	1;1;1	A;C;G	1;1;1	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	144	mdtH	1209	133	98.5	mdtH.l15.c4.ctg.4	133	1.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	89	91	TTG	3;3;3	T;T;G	3;3;3	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	210	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1360	7.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	717	719	TCC	8;8;9	T;C;C	7;7;9	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	513	176	mdtN	1032	186	98.92	mdtN.l15.c30.ctg.1	354	4.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	513	176	mdtN	1032	677	97.93	mdtN.l15.c30.ctg.2	710	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	513	176	mdtN	1032	184	98.37	mdtN.l15.c30.ctg.3	184	7.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	181	183	ATT	1;1;1	A;T;T	1;1;1	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	1054	98.58	mdtO.l6.c4.ctg.1	1244	8.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	23	25	GTC	9;9;10	G;T;C	9;9;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	1054	98.58	mdtO.l6.c4.ctg.1	1244	8.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	53	55	ATA	16;16;15	A;T;A	16;16;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	1054	98.58	mdtO.l6.c4.ctg.1	1244	8.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	161	163	TCT	3;3;4	T;C;T	3;3;4	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	1054	98.58	mdtO.l6.c4.ctg.1	1244	8.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	548	550	GCG	5;4;5	G;C;G	5;4;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	1054	98.58	mdtO.l6.c4.ctg.1	1244	8.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	761	763	ATC	2;2;2	A;T;C	2;2;2	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	959	97.81	mdtO.l6.c4.ctg.2	1094	7.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	166	168	ATG	4;4;4	A;T;G	4;4;4	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	959	97.81	mdtO.l6.c4.ctg.2	1094	7.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	232	234	ATC	1;1;1	A;T;C	1;1;1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	959	97.81	mdtO.l6.c4.ctg.2	1094	7.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	481	483	CGC	9;9;9	C;G;C	9;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	959	97.81	mdtO.l6.c4.ctg.2	1094	7.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	847	849	AGC	8;8;9	A;G;C	8;8;8	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	513	352	mdtO	2052	959	97.81	mdtO.l6.c4.ctg.2	1094	7.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1048	1050	GTG	9;8;8	G;T;G	9;8;8	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	425	427	GCG	6;6;6	G;C;G	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	599	601	ACC	5;5;5	A;C;C	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	671	673	CGC	6;6;7	C;G;C	6;6;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	788	790	GCT	8;8;8	G;C;T	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	872	874	AAA	5;5;5	A;A;A	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	890	892	CGA	5;5;4	C;G;A	5;5;4	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1055	1057	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	1356	97.94	mdtP.l6.c4.ctg.1	1396	7.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1067	1069	GAT	5;5;5	G;A;T	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	515	202	mdtP	1467	112	98.21	mdtP.l6.c4.ctg.2	271	2.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	89	91	GCT	6;6;6	G;C;T	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	416	mfd	3447	2594	98.96	mfd.l6.c30.ctg.1	2594	6.0	0	.	p	.	0	D382A	NONSYN	1144	1146	GAC	317	319	GCC	3;3;3	G;C,A;C	3;0,3;3	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	416	mfd	3447	2594	98.96	mfd.l6.c30.ctg.1	2594	6.0	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	482	484	AAG	2;2;2	A;A;G	2;2;2	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	416	mfd	3447	2594	98.96	mfd.l6.c30.ctg.1	2594	6.0	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	1559	1561	CTG	7;8;7	C;T;G	7;7;7	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	416	mfd	3447	482	99.38	mfd.l6.c30.ctg.2	482	6.4	0	.	p	.	0	L171I	NONSYN	511	513	CTC	479	481	ATC	1;1;1	A,C;T;C	0,1;1;1	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	416	mfd	3447	366	99.45	mfd.l6.c30.ctg.3	366	7.7	0	.	p	.	0	R165G	NONSYN	493	495	CGC	36	38	GGC	1;1;2	G,C;G;C	0,1;1;2	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	26	mgrB	144	140	100.0	mgrB.l15.c30.ctg.1	150	4.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	276	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1809	7.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	859	861	AAC	5;4;5	A;A;C	5;4;5	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	276	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1809	7.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1405	1407	ATA	8;8;8	A;T;A	8;8;8	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	230	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1397	8.4	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1078	1080	GTG	8;8;8	G;T;G	8;8;8	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	230	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1397	8.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1156	1158	GAT	9;9;9	G;A;T	8;9;9	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	230	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1397	8.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1159	1161	CTG	9;9;9	C;T;G	9;9;9	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	293	99.32	nfsA.l6.c4.ctg.1	390	4.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	129	131	GAC	7;7;7	G;A;C	7;7;7	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	293	99.32	nfsA.l6.c4.ctg.1	390	4.4	1	SNP	p	R203L	0	.	.	607	609	CGT	177	179	CGT	4;4;4	C;G;T	4;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	293	99.32	nfsA.l6.c4.ctg.1	390	4.4	1	SNP	p	R203C	0	.	.	607	609	CGT	177	179	CGT	4;4;4	C;G;T	4;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	428	99.07	nfsA.l6.c4.ctg.2	441	4.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	89	91	TGT	4;4;4	T;G;T	4;4;4	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	428	99.07	nfsA.l6.c4.ctg.2	441	4.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	359	361	ACC	6;6;6	A;C;C	6;6;6	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	428	99.07	nfsA.l6.c4.ctg.2	441	4.5	1	SNP	p	R15C	0	.	.	43	45	CGC	53	55	CGC	6;6;5	C;G;C	6;6;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	428	99.07	nfsA.l6.c4.ctg.2	441	4.5	1	SNP	p	S33R	0	.	.	97	99	AGC	107	109	AGC	4;4;4	A;G;C	4;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	76	nfsA	723	428	99.07	nfsA.l6.c4.ctg.2	441	4.5	1	SNP	p	G131D	0	.	.	391	393	GGC	401	403	GGC	4;4;4	G;G;C	4;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	218	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1195	9.1	1	SNP	p	G141D	0	.	.	421	423	GGT	484	486	GGT	6;6;6	G;G;T	6;6;6	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	218	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1195	9.1	1	SNP	p	G141E	0	.	.	421	423	GGT	484	486	GGT	6;6;6	G;G;T	6;6;6	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	218	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1195	9.1	1	SNP	p	R154A	0	.	.	460	462	CGT	523	525	CGT	6;6;6	C;G;T	6;6;6	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	218	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1195	9.1	1	SNP	p	R154D	0	.	.	460	462	CGT	523	525	CGT	6;6;6	C;G;T	6;6;6	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	502	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2517	10.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1803	1805	TCG	12;12;11	T;C;G	12;12;11	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	502	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2517	10.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2418	2420	AAC	8;8;9	A;A;C	8;8;9	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	502	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2517	10.6	1	SNP	p	A85T	0	.	.	253	255	GCG	432	434	GCG	12;12;12	G;C;G	12;11;11	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	502	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2517	10.6	1	SNP	p	D111H	0	.	.	331	333	GAT	510	512	GAT	7;7;8	G;A;T	7;7;8	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	502	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2517	10.6	1	SNP	p	S129P	0	.	.	385	387	TCC	564	566	TCC	14;14;13	T;C;C	14;14;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	512	282	parE_1	1893	415	97.35	parE_1.l15.c30.ctg.1	415	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	512	282	parE_1	1893	689	98.4	parE_1.l15.c30.ctg.2	689	10.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	263	265	GAT	8;8;7	G;A;T	8;8;7	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	512	282	parE_1	1893	186	96.24	parE_1.l15.c30.ctg.3	187	6.1	0	.	p	.	0	Y222S	NONSYN	664	666	TAC	5	7	TCC	1;1;3	T;C;C	1;0;3	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	512	282	parE_1	1893	154	98.05	parE_1.l15.c30.ctg.5	180	6.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	270	patA	1380	1380	99.86	patA.l6.c4.ctg.1	1774	8.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1288	1290	GAT	15;15;14	G;A;T	15;15;14	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	V146F	0	.	.	436	438	GTT	615	617	GTT	7;7;7	G;T;T	7;7;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1716	1718	CAG	13;14;14	C;A;G	13;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1716	1718	CAG	13;14;14	C;A;G	13;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1755	1757	CAC	10;10;11	C;A;C	10;10;11	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1764	1766	CGT	8;8;8	C;G;T	8;8;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1764	1766	CGT	8;8;8	C;G;T	8;8;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1770	1772	TCC	8;7;7	T;C;C	8;7;7	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1776	1778	CTC	6;6;5	C;T;C	6;6;5	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1866	1868	ACC	8;8;8	A;C;C	8;8;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1869	1871	CCT	9;9;8	C;C;T	9;9;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	840	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4430	10.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2238	2240	CGT	14;14;13	C;G;T	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	.	n	.	0	A226G	SNP	226	226	A	341	341	G	82	G	82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	.	n	.	0	C719T	SNP	719	719	C	834	834	T	67	T,C	38,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	A794G	0	.	.	794	794	A	909	909	A	69	A	69	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	A794T	0	.	.	794	794	A	909	909	A	69	A	69	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	G926A	0	.	.	926	926	G	1041	1041	G	54	G	52	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	G926C	0	.	.	926	926	G	1041	1041	G	54	G	52	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	G926T	0	.	.	926	926	G	1041	1041	G	54	G	52	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1634	1634	A	59	A	59	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1634	1634	A	59	A	59	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1634	1634	A	59	A	59	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1121	1121	G	63	G,C	49,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	A79G	.	79	79	A	194	194	A	64	A,G	54,9	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	T273A	.	273	273	T	388	388	T	61	T,A	47,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	C210A	.	210	210	C	325	325	C	74	C,A	58,16	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1125	1125	T	64	T,C	48,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1153	1153	C	66	C,T	47,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	A250T	.	250	250	A	365	365	A	65	A,T	52,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	T90C	.	90	90	T	205	205	T	65	T,C	53,12	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	G474A	.	474	474	G	589	589	G	70	G,A	54,16	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	A253T	.	253	253	A	368	368	A	66	A,T	53,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	2240	rrsB+	1542	1542	99.87	rrsB+.l6.c17.ctg.1	1836	63.5	0	HET	.	.	.	G1002A	.	1002	1002	G	1117	1117	G	61	G,A	47,13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	122	soxR	465	465	100.0	soxR.l15.c30.ctg.1	631	9.6	1	SNP	p	R20H	0	.	.	58	60	CGC	205	207	CGC	12;11;11	C;G;C	12;11;11	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	122	soxR	465	465	100.0	soxR.l15.c30.ctg.1	631	9.6	1	SNP	p	G121D	0	.	.	361	363	GGT	508	510	GGT	12;12;12	G;G;T	12;12;12	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	76	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	502	6.6	1	SNP	p	A12S	0	.	.	34	36	GCA	43	45	GCA	10;10;10	G;C;A	10;10;10	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	298	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1810	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
